Literature DB >> 9390770

Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease.

M A Lovell1, W D Ehmann, M P Mattson, W R Markesbery.   

Abstract

4-Hydroxynonenal (4-HNE), an aldehyde by-product of the peroxidation of fatty acids, has been shown to have toxic properties for neurons in culture. In light of increasing evidence that oxidative stress contributes to the neurodegenerative process in Alzheimer's disease (AD), we quantified levels of free and protein-bound 4-HNE in the ventricular fluid from 19 AD subjects and 13 control subjects by high-pressure liquid chromatography and dot-blot immunoassay. Free 4-HNE levels were found to be significantly elevated in the ventricular fluid of AD subjects compared with control subjects (p = 0.0096). These results demonstrate increased lipid peroxidation in AD brain and suggest a role for 4-HNE in the neurodegenerative process.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9390770     DOI: 10.1016/s0197-4580(97)00108-5

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  87 in total

1.  Human, but not bovine, oxidized cerebral spinal fluid lipoproteins disrupt neuronal microtubules.

Authors:  M D Neely; L L Swift; T J Montine
Journal:  Lipids       Date:  2000-11       Impact factor: 1.880

2.  Effects of staurosporine, U-73122, wortmannin, 4-hydroxynonenal and sodium azide upon the release of secreted beta-amyloid precursor protein from human platelets in response to thrombin stimulation.

Authors:  H L Hedin; L Nilsson; C J Fowler
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

3.  Naturally occurring genetic variability in expression of Gsta4 is associated with differential survival of axotomized rat motoneurons.

Authors:  Mikael Ström; Faiez Al Nimer; Rickard Lindblom; Jens Randel Nyengaard; Fredrik Piehl
Journal:  Neuromolecular Med       Date:  2011-12-08       Impact factor: 3.843

4.  Sesaminol glucosides protect β-amyloid induced apoptotic cell death by regulating redox system in SK-N-SH cells.

Authors:  Min Young Um; Ji Yun Ahn; Mi Kyung Kim; Tae Youl Ha
Journal:  Neurochem Res       Date:  2011-12-06       Impact factor: 3.996

5.  Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease.

Authors:  Roy G Cutler; Jeremiah Kelly; Kristin Storie; Ward A Pedersen; Anita Tammara; Kimmo Hatanpaa; Juan C Troncoso; Mark P Mattson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-15       Impact factor: 11.205

6.  A lifetime of dedication to the old in his Kentucky home.

Authors:  Mark P Mattson
Journal:  Neuromolecular Med       Date:  2010-07-08       Impact factor: 3.843

7.  Promotion of oxidative lipid membrane damage by amyloid beta proteins.

Authors:  Ian V J Murray; Michael E Sindoni; Paul H Axelsen
Journal:  Biochemistry       Date:  2005-09-20       Impact factor: 3.162

8.  Membrane-mediated amyloidogenesis and the promotion of oxidative lipid damage by amyloid beta proteins.

Authors:  Ian V J Murray; Liu Liu; Hiroaki Komatsu; Kunihiro Uryu; Gang Xiao; John A Lawson; Paul H Axelsen
Journal:  J Biol Chem       Date:  2007-01-24       Impact factor: 5.157

9.  Altered 8-oxoguanine glycosylase in mild cognitive impairment and late-stage Alzheimer's disease brain.

Authors:  Changxing Shao; Shuling Xiong; Guo-Min Li; Liya Gu; Guogen Mao; William R Markesbery; Mark A Lovell
Journal:  Free Radic Biol Med       Date:  2008-06-11       Impact factor: 7.376

Review 10.  Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression.

Authors:  D Allan Butterfield; Aaron M Swomley; Rukhsana Sultana
Journal:  Antioxid Redox Signal       Date:  2013-02-14       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.